SOPHIRIS BIO INC. OMNIBUS AMENDMENT TO WARRANTS TO PURCHASE COMMON SHARESSophiris Bio Inc. • February 18th, 2014 • Pharmaceutical preparations • New York
This Omnibus Amendment to Warrants to Purchase Common Shares (this “Agreement”) is made as of February 14, 2014, by and among Sophiris Bio Inc., a corporation amalgamated under the Business Corporations Act (British Columbia), f/k/a Protox Therapeutics Inc. (the “Company”), and Oxford Finance LLC a [Delaware] limited liability company (the “Holder”) to amend those certain Warrants to Purchase Common Shares (each a “Warrant” and together the “Warrants”) set forth in Attachment 1 attached hereto. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Warrants.
